3386 · COSMO BIO COMPANY, LIMITED · Financials
Market Cap
7.01B JPY
Shares
5.70M
Volume · Nov 12
1700
Avg daily vol (3M)
4093
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
10.77B
+7.3%
FY2025
Net Income
337M
+28.6%
FY2025
Gross Margin
34.39%
+1.2pp
FY2025
Operating Margin
3.19%
0pp
FY2025
Operating Cash Flow
595M
+146.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| JPY | 10.77B | 10.04B | 9.34B | 9.55B | 9.23B |
| JPY | 7.06B | 6.71B | 6.09B | 6.11B | 5.57B |
| JPY | 3.7B | 3.33B | 3.25B | 3.44B | 3.66B |
| JPY | 343M | 318M | 519M | 816M | 1.05B |
| JPY | 504M | 369M | 653M | 790M | 1.1B |
| JPY | 170M | 99M | 191M | 238M | 330M |
| JPY | 337M | 262M | 442M | 517M | 737M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2021–FY2025: 1.18B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.